好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Case of Acute Necrotizing Encephalopathy in a Patient With Influenza
Neuro Trauma and Critical Care
P2 - Poster Session 2 (11:45 AM-12:45 PM)
19-006
We present a case of rapidly progressive encephalitis originating in the pons and radiating superiorly to involve the hippocampi, accompanied by severe myotonia with profound electrolyte derangement.

This is a 57-year old-female with seronegative lupus (on hydroxychloroquine and belimumab) who presented with acute onset dysarthria and gait instability. Stroke code imaging was negative. She tested positive for Influenza A and oseltamivir was started, later changed to peramivir. Her mental status declined within hours requiring intubation.

Magnetic resonance imaging (MRI) demonstrated symmetrical T2 hyperintense lesions with diffusion restriction at the pons. Repeat MRI two days after disclosed marked progression of the symmetrical brainstem edema, involving the temporal lobes through the hippocampi. Cerebrospinal fluid (CSF) revealed protein of 181. She was transferred to a tertiary care hospital.

Patient was unresponsive on unsedated exam. Diffuse myotonia was observed, with creatinine kinase (CK) over 70,000. EEG revealed multiple generalized seizures with focal onset over the left temporal lobe. Repeat CSF disclosed protein of 665 and few cells. Serum and CSF revealed elevations in interleukin-6 in the serum (213) and CSF (104) and was negative for toxins, ganglioside antibodies, and antibodies associated with autoimmune encephalitis (Mayo Clinic ENC2 panel). Profound refractory hyperkalemia resulted in cardiac arrest.

Autopsy revealed multifocal cerebral and cord hemorrhage with bland coagulative necrosis consistent with infarction without lymphocytic or neutrophilic infiltration or malignancy. There was acute lung injury attributed to influenza, and renal changes consistent with Class II lupus nephritis.

NA
NA
Her cause of death was determined to be acute necrotizing encephalopathy (ANE), a severe neurologic condition involving fulminant cerebral edema usually triggered by a viral infection. Pathophysiology has not been entirely characterized but is thought to involve a cytokine storm in susceptible hosts. Prompt identification is essential so that high-dose steroids, plasmapheresis, tocilizumab, and/or intravenous immunoglobulin can be initiated.
Authors/Disclosures
Kristen Watkins, MD
PRESENTER
Dr. Watkins has nothing to disclose.
Catherine W. Imossi, MD Dr. Imossi has nothing to disclose.
Eddie Louie Eddie Louie has nothing to disclose.
Terrence Thomas, MD Dr. Thomas has nothing to disclose.
Laura Methvin, MD No disclosure on file
Christopher William Christopher William has nothing to disclose.
Ilya Kister, MD, FAAN (NYU School of Medicine) Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Kara R. Melmed, MD (NYU Langone Neurology Associates) Dr. Melmed has nothing to disclose.